1. Home
  2. PHGE vs DFLI Comparison

PHGE vs DFLI Comparison

Compare PHGE & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • DFLI
  • Stock Information
  • Founded
  • PHGE 2015
  • DFLI 2020
  • Country
  • PHGE Israel
  • DFLI United States
  • Employees
  • PHGE N/A
  • DFLI N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • PHGE Health Care
  • DFLI Technology
  • Exchange
  • PHGE Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • PHGE 13.3M
  • DFLI 15.2M
  • IPO Year
  • PHGE N/A
  • DFLI N/A
  • Fundamental
  • Price
  • PHGE $0.63
  • DFLI $0.94
  • Analyst Decision
  • PHGE Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • PHGE 2
  • DFLI 5
  • Target Price
  • PHGE $23.00
  • DFLI $15.66
  • AVG Volume (30 Days)
  • PHGE 117.4K
  • DFLI 75.3K
  • Earning Date
  • PHGE 05-19-2025
  • DFLI 03-24-2025
  • Dividend Yield
  • PHGE N/A
  • DFLI N/A
  • EPS Growth
  • PHGE N/A
  • DFLI N/A
  • EPS
  • PHGE N/A
  • DFLI N/A
  • Revenue
  • PHGE N/A
  • DFLI $50,645,000.00
  • Revenue This Year
  • PHGE N/A
  • DFLI $58.40
  • Revenue Next Year
  • PHGE N/A
  • DFLI $123.90
  • P/E Ratio
  • PHGE N/A
  • DFLI N/A
  • Revenue Growth
  • PHGE N/A
  • DFLI N/A
  • 52 Week Low
  • PHGE $0.48
  • DFLI $0.89
  • 52 Week High
  • PHGE $4.99
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 49.87
  • DFLI 26.30
  • Support Level
  • PHGE $0.48
  • DFLI $0.95
  • Resistance Level
  • PHGE $0.58
  • DFLI $1.03
  • Average True Range (ATR)
  • PHGE 0.06
  • DFLI 0.13
  • MACD
  • PHGE 0.00
  • DFLI 0.02
  • Stochastic Oscillator
  • PHGE 68.16
  • DFLI 8.08

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: